Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge.
There is a critical need for new influenza vaccines able to protect against constantly emerging divergent virus strains. This will be sustained by the induction of vigorous cellular responses and humoral immunity capable of acting at the portal of entry of this pathogen. In this study we evaluate th...
Main Authors: | Maria Victoria Sanchez, Thomas Ebensen, Kai Schulze, Diego Cargnelutti, Paulina Blazejewska, Eduardo A Scodeller, Carlos A Guzmán |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4139298?pdf=render |
Similar Items
-
Cellular hnRNP A2/B1 interacts with the NP of influenza A virus and impacts viral replication.
by: Cheng-Kai Chang, et al.
Published: (2017-01-01) -
Intranasal Immunization with Pressure Inactivated Avian Influenza Elicits Cellular and Humoral Responses in Mice.
by: Shana P C Barroso, et al.
Published: (2015-01-01) -
The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post Immunization
by: Thomas Ebensen, et al.
Published: (2019-02-01) -
Characterization of Influenza A viral PA-interacting cellular protein hnRNP M
by: Hsuan Liu, et al.
Published: (2012) -
Cytokines: The Future of Intranasal Vaccine Adjuvants
by: Afton L. Thompson, et al.
Published: (2011-01-01)